Literature DB >> 19945323

Endothelial progenitor cells in arthritis-associated vasculogenesis and atherosclerosis.

Angéla Pákozdi, Timea Besenyei, György Paragh, Alisa E Koch, Zoltán Szekanecz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945323      PMCID: PMC2919750          DOI: 10.1016/j.jbspin.2009.04.007

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  20 in total

Review 1.  Accelerated atherosclerosis in autoimmune rheumatic diseases.

Authors:  Yehuda Shoenfeld; Roberto Gerli; Andrea Doria; Eiji Matsuura; Marco Matucci Cerinic; Nicoletta Ronda; Luis J Jara; Mahmud Abu-Shakra; Pier Luigi Meroni; Yaniv Sherer
Journal:  Circulation       Date:  2005-11-22       Impact factor: 29.690

2.  Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.

Authors:  Lennart T H Jacobsson; Carl Turesson; Anders Gülfe; Meliha C Kapetanovic; Ingemar F Petersson; Tore Saxne; Pierre Geborek
Journal:  J Rheumatol       Date:  2005-07       Impact factor: 4.666

3.  Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis.

Authors:  Jacob N Ablin; Viktoria Boguslavski; Valerie Aloush; Ori Elkayam; Daphna Paran; Dan Caspi; Jacob George
Journal:  Life Sci       Date:  2006-08-05       Impact factor: 5.037

4.  Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells.

Authors:  K Herbrig; S Haensel; U Oelschlaegel; F Pistrosch; S Foerster; J Passauer
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

5.  Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy.

Authors:  Johannes Grisar; Daniel Aletaha; Carl W Steiner; Theresa Kapral; Sabine Steiner; Marcus Säemann; Ilse Schwarzinger; Barbara Buranyi; Günter Steiner; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2007-02-09       Impact factor: 19.103

Review 6.  Circulating endothelial progenitor cells as a link between synovial vascularity and cardiovascular mortality in rheumatoid arthritis.

Authors:  M A Akhavani; H Larsen; E Paleolog
Journal:  Scand J Rheumatol       Date:  2007 Mar-Apr       Impact factor: 3.641

Review 7.  Accelerated atherosclerosis in rheumatoid arthritis.

Authors:  Zoltán Szekanecz; György Kerekes; Henriett Dér; Zsuzsa Sándor; Zoltán Szabó; Anikó Végvári; Enikö Simkovics; Lilla Soós; Agnes Szentpétery; Timea Besenyei; Gabriella Szücs; Sándor Szántó; László Tamási; Gyula Szegedi; Yehuda Shoenfeld; Pál Soltész
Journal:  Ann N Y Acad Sci       Date:  2007-06       Impact factor: 5.691

8.  The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium.

Authors:  Matthew D Silverman; Christian S Haas; Ali M Rad; Ali S Arbab; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2007-06

Review 9.  Endothelial progenitor cells and rheumatic disorders.

Authors:  Jérôme Avouac; Georges Uzan; André Kahan; Catherine Boileau; Yannick Allanore
Journal:  Joint Bone Spine       Date:  2008-01-29       Impact factor: 4.929

10.  The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis.

Authors:  Isabelle Petit; David Jin; Shahin Rafii
Journal:  Trends Immunol       Date:  2007-06-07       Impact factor: 16.687

View more
  2 in total

1.  Vasculogenesis in rheumatoid arthritis.

Authors:  Zoltán Szekanecz; Alisa E Koch
Journal:  Arthritis Res Ther       Date:  2010-03-18       Impact factor: 5.156

2.  GATA4 regulates angiogenesis and persistence of inflammation in rheumatoid arthritis.

Authors:  Wanwan Jia; Weijun Wu; Di Yang; Chenxi Xiao; Mengwei Huang; Fen Long; Zhenghua Su; Ming Qin; Xinhua Liu; Yi Zhun Zhu
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.